{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "31501150",
  "DateCompleted": {
    "Year": "2020",
    "Month": "09",
    "Day": "11"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "07",
    "Day": "16"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2019",
        "Month": "09",
        "Day": "09"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1158/1055-9965.EPI-19-0105"
    ],
    "Journal": {
      "ISSN": "1538-7755",
      "JournalIssue": {
        "Volume": "28",
        "Issue": "12",
        "PubDate": {
          "Year": "2019",
          "Month": "Dec"
        }
      },
      "Title": "Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology",
      "ISOAbbreviation": "Cancer Epidemiol Biomarkers Prev"
    },
    "ArticleTitle": "Electronic Cigarette Use among Survivors of Smoking-Related Cancers in the United States.",
    "Pagination": {
      "StartPage": "2087",
      "EndPage": "2094",
      "MedlinePgn": "2087-2094"
    },
    "Abstract": {
      "AbstractText": [
        "The prevalence of electronic cigarette (e-cigarette) use and its impact on smoking cessation among cancer survivors in the United States is largely unknown. We sought to estimate the prevalence of e-cigarette use and examine its associations with cigarette smoking and smoking quit attempts among smoking-related cancer survivors in the United States.",
        "We obtained data from the 2014-2017 annual cycles of the National Health Interview Survey for participants with self-reported history of smoking-related cancer(s). We calculated the prevalence of current e-cigarette use and utilized multinomial logistic regression in examining the independent association between e-cigarette use and cigarette smoking. Appropriate survey weights were applied in estimating the prevalence rates, relative risk ratios (RRR), ORs, and confidence intervals (CI).",
        "Our sample comprised 3,162 smoking-related cancer survivors. The prevalence of current e-cigarette use was 3.18% (95% CI, 2.40-3.96). Current e-cigarette users were 83 times as likely as never users to be current cigarette smokers (RRR, 82.89; 95% CI, 16.54-415.37). Among those with a history of cigarette smoking, current e-cigarette users were 90% less likely to be former smokers (OR, 0.10; 95% CI, 0.05-0.18). No association was seen between current e-cigarette use and a smoking quit attempt in the prior year.",
        "E-cigarette use among cigarette ever smokers was associated with a lower likelihood of being a former smoker/having quit smoking, and e-cigarette use was not associated with smoking quit attempts.",
        "Our findings do not provide evidence that e-cigarette use facilitates smoking cessation among smoking-related cancer survivors."
      ],
      "CopyrightInformation": "\u00a92019 American Association for Cancer Research."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Boston Medical Center, Boston, Massachusetts. oladimeji.akinboro@gmail.com."
          }
        ],
        "LastName": "Akinboro",
        "ForeName": "Oladimeji",
        "Initials": "O"
      },
      {
        "Identifier": [
          "0000-0003-3075-7541"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Boston Medical Center, Boston, Massachusetts."
          }
        ],
        "LastName": "Nwabudike",
        "ForeName": "Stanley",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Hartford Hospital Cancer Center, Hartford, Connecticut."
          }
        ],
        "LastName": "Elias",
        "ForeName": "Rawad",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Meharry Medical College, Nashville, Tennessee."
          }
        ],
        "LastName": "Balasire",
        "ForeName": "Oluseyi",
        "Initials": "O"
      },
      {
        "Identifier": [
          "0000-0001-5230-7037"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Mayo Clinic Health System Franciscan Medical Center, LaCrosse, Wisconsin."
          }
        ],
        "LastName": "Ola",
        "ForeName": "Olatunde",
        "Initials": "O"
      },
      {
        "Identifier": [
          "0000-0003-2671-5680"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Memorial Sloan Kettering Cancer Center, New York, New York."
          }
        ],
        "LastName": "Ostroff",
        "ForeName": "Jamie S",
        "Initials": "JS"
      }
    ],
    "GrantList": [
      {
        "GrantID": "P30 CA008748",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Cancer Epidemiol Biomarkers Prev",
    "NlmUniqueID": "9200608",
    "ISSNLinking": "1055-9965"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "psychology",
        "statistics & numerical data"
      ],
      "DescriptorName": "Cancer Survivors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cross-Sectional Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Follow-Up Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "etiology",
        "pathology",
        "psychology"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prevalence"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prognosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Self Report"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Smoking"
    },
    {
      "QualifierName": [
        "psychology",
        "statistics & numerical data"
      ],
      "DescriptorName": "Smoking Cessation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Surveys and Questionnaires"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "United States"
    },
    {
      "QualifierName": [
        "epidemiology",
        "psychology"
      ],
      "DescriptorName": "Vaping"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Young Adult"
    }
  ]
}